A calibrated measuring device, such as an oral dosing syringe or oral dosing cup, should be used to measure and deliver the prescribed dose accurately. The Food and Drug Administration (FDA) has ...
April 26, 2011 — The US Food and Drug Administration has approved lamotrigine extended release for conversion to monotherapy for partial seizures. This is a new indication for the GlaxoSmithKline ...
LOS ANGELES -- The FDA's warning about arrhythmia risk with lamotrigine (Lamictal) based on in vitro data wasn't borne out in observational cohorts of people with epilepsy, although the risk did ...
Findings published by The BMJ reinforce previous research linking use of the antiseizure drug valproate during pregnancy to neurodevelopmental disorders such as ADHD and autism in children, and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results